Clinical Trials in the Netherlands

by Egle Pavyde | Mar 21, 2026 | Clinical Trials by Country

Clinical Trials in the Netherlands: Approval Timelines, Regulatory Framework, and Why the Netherlands Is One of Europe’s Fastest Markets The Netherlands is widely regarded as one of the most efficient countries in Europe for conducting clinical trials. Known for fast...

Clinical Trials in Belgium

by Egle Pavyde | Mar 20, 2026 | Clinical Trials by Country

Clinical Trials in Belgium: A Specialist Hub for Oncology and Rare Diseases in Western Europe Belgium occupies a distinctive position in European clinical research. Despite its relatively small population of approximately 11.6 million, the country hosts some of the...

Clinical Trials in Switzerland

by Egle Pavyde | Mar 19, 2026 | Clinical Trials by Country

Clinical Trials in Switzerland: Precision Medicine, Phase I Expertise, and a Separate Regulatory Framework Switzerland is one of Europe’s most scientifically advanced clinical research environments. The country is home to a disproportionate share of global...

Clinical Trials in Portugal

by Egle Pavyde | Mar 18, 2026 | Clinical Trials by Country

Clinical Trials in Portugal: A Competitive, Cost-Effective Option for Southern European Research Portugal has steadily grown its clinical research profile over the past decade, establishing itself as a credible and cost-effective option for sponsors seeking Southern...

Clinical Trials in Denmark

by Egle Pavyde | Mar 17, 2026 | Clinical Trials by Country

Clinical Trials in Denmark: Fast Approvals, World-Class Registries, High Standards Denmark is one of Europe’s most efficient clinical trial environments. With a population of approximately 5.9 million and a highly digitalised, universal healthcare system,...